Brain Vascular Malformation Consortium (BVMC)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2009
  • Initiating Organization: NIH Rare Disease Clinical Research Network
  • Initiator Type: Government
  • Rare disease
  • Disease focus:
    Hereditary Hemorrhagic Telangiectasia, Sturge-Weber Syndrome, Cerebral cavernous Malformations
  • Location: North America

Abstract

The Brain Vascular Malformation Consortium (BVMC) is an integrated group of academic medical centers, patient support groups, and clinical research resources dedicated to conducting clinical research in different forms of brain vascular malformations and improving the care of patients with Sturge-Weber syndrome (SWS), Cerebral Cavernous Malformations (CCM), and Hereditary Hemorrhagic Telangiectasia (HHT). Funded by the National Institutes of Health (NIH), BVMC is part of the Rare Diseases Clinical Research Network.

Mission

BVMC’s mission is to conduct clinical research and clinical trials to learn more about these diseases with the goal of developing new and better treatments to improve the care of patients with brain vascular malformations. It also seeks to provide up-to-date information for patients to help them manage their diseases and to assist in connecting patients with support groups, expert doctors, and clinical research opportunities.

BVMC’s goals are as follows:

Structure & Governance

This consortium is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS). The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment, and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.

Funding and scientific oversight for the RDCRN are provided by NCATS and 10 NIH components: Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; the National Heart, Lung and Blood Institute; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; and Office of the Director. In addition, patient advocacy groups provide funds for many of the projects.

Points of Contact

Michael T. Lawton, M.D.
Program Director
University of California, San Francisco
505 Parnassus Ave, M780C
San Francisco, CA 94143-0112
email: Michael.Lawton@ucsf.edu
 
Douglas A. Marchuk, Ph.D.
Co-Director
Professor, Department of Molecular Genetics and Microbiology
Duke University Medical Center
Durham, NC 27710
email: march004@mc.duke.edu

Sponsors & Partners

Participant/Sponsor

Angioma Alliance

Barrow Neurological Institute

Baylor College of Medicine, Texas Children’s Hospital

Cincinnati Children’s Hospital

Cure HHT

Georgia Health Sciences University

Hospital for Sick Children, Toronto

Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore

Johns Hopkins University

Mayo Clinic, Rochester, NY

Nationwide Children’s Hospital, Columbus

New York University Comprehensive Epilepsy Center

St. Antonius Hospital, Nieuwegein

St. Michael’s Hospital, Toronto

Thomas Jefferson University—Wills Eye Institute

University of California, Los Angeles

University of California, San Francisco

University of New Mexico, Health Sciences Center

University of North Carolina, Chapel Hill

University of Utah, Salt Lake City

Washington University, St. Louis

Wayne State University


Last Updated: 04/06/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.